Filtered By:
Source: Genes and Diseases
Condition: Keloids
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1
In conclusion, AMF siRNA is expected to be a novel strategy to treat KD by inhibiting signaling pathway of RhoA/ROCK1.
Source: Genes and Diseases - July 10, 2018 Category: Genetics & Stem Cells Source Type: research
